91. バッド・キアリ症候群 Budd-Chiari syndrome Clinical trials / Disease details
臨床試験数 : 4 / 薬物数 : 5 - (DrugBank : 4) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2100046725 | 2022-01-01 | 2021-05-27 | The efficacy and safety of Warfarin and Rivaroxaban to prevent re-occlusion for Budd-Chiari syndrome with membranous obstruction after percutanouse balloon angioplasty | To compare the efficacy and safety of Warfarin and Rivaroxaban to prevent re-occlusion for Budd-Chiari syndrome with membranous obstruction after percutanouse balloon angioplasty | Budd-Chiari syndrome | Warfarin group:oral take Warfarin;Rivaroxaban group:oral take rivaroxaban; | The First Affiliated Hospital of Zhengzhou University | NULL | Recruiting | 18 | 75 | Both | Warfarin group:40;Rivaroxaban group:40; | N/A | China |
| 2 | EUCTR2014-005162-29-NL (EUCTR) | 09/04/2020 | 13/06/2019 | Treatment of thrombosis in the abdominal veins | Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study - RIVASVT100 | Splanchnic vein thrombosis (SVT) is an unusual site manifestation of venous thromboembolism (VTE). It includes the Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), mesenteric vein thrombosis (MVT) and splenic vein thrombosis (spVT). PVT is the most frequent manifestation of SVT, followed by MVT. ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] | Trade Name: rivaroxaban 20 mg Product Name: rivaroxaban | University of Insubria | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 100 | Phase 4 | France;Canada;Germany;Netherlands;Italy | ||
| 3 | ChiCTR1800017925 | 2018-08-31 | 2018-08-22 | D-printed bidirectional angiography versus traditional angiography for the diagnosis and effect of Budd–Chiari Syndrome With Inferior Vena Cava Obstruction:-----A Prospective Single blind Randomized Trial | D-printed bidirectional angiography versus traditional angiography for the diagnosis and effect of Budd–Chiari Syndrome With Inferior Vena Cava Obstruction:-----A Prospective Single blind Randomized Trial | Budd-Chiari syndrome | Gold Standard:traditional angiography;Index test:3D-printed bidirectional angiography; | Affiliated Hospital of Xuzhou Medical University | NULL | Pending | 19 | 68 | Both | Target condition:60;Difficult condition:0 | NULL | |
| 4 | JPRN-UMIN000015319 | 2012/06/01 | 12/10/2014 | The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome | The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome - The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome | Portal vein thrombosis or Budd-Chiari syndrome | dabigatran | Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology | NULL | Recruiting | 20years-old | 70years-old | Male and Female | 20 | Not selected | Japan |